CliffBio
small molecule

QUARTETTE

ETHINYL ESTRADIOL; LEVONORGESTREL

Loss of exclusivityMarch 2029latest FDA-listed patent expiry
CompanyTEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC

Drug detail

Brand nameQUARTETTE
Active ingredientETHINYL ESTRADIOL; LEVONORGESTREL
Strength0.02MG,0.15MG;0.025MG,0.15MG;0.03MG,0.15MG;0.01MG,N/A
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2013
Marketing statusRX

Listed patents

PatentExpiresType
8415332March 2029product

More from TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

QUARTETTE patent cliff — loss of exclusivity March 2029 | CliffBio